Before you sell to, join or invest in PIROUETTE PHARMA INC.
MentionFox check on PIROUETTE PHARMA INC.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/pirouette-pharma-inc-form-d-25000001
Check PIROUETTE PHARMA INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about PIROUETTE PHARMA INC.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
PIROUETTE PHARMA INC. filed a Form D with the Securities and Exchange Commission on 2025-04-01.
PIROUETTE PHARMA INC. filed a Form D notice of an exempt securities offering with the SEC on April 1, 2025. The filing reports $2.35M sold. Its industry group is Pharmaceuticals. It names CONOR CULLINANE (Executive Officer, Director, Promoter), JOSEPH NEMMERS (Director), PARINAZ MOTAMEDY (Director) (SEC Form D, April 1, 2025).
Is this your company?
Sell to companies like PIROUETTE PHARMA INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns PIROUETTE PHARMA INC.
Free to see. No signup.
More on the people and the money behind PIROUETTE PHARMA INC., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when PIROUETTE PHARMA INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when PIROUETTE PHARMA INC. raises, hires or launches. No email unless you switch it on.
Watch PIROUETTE PHARMA INC. →Get the full cited report on PIROUETTE PHARMA INC.
What the filing shows about PIROUETTE PHARMA INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on PIROUETTE PHARMA INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives PIROUETTE PHARMA INC.'s address as 200 International Drive, Suite 170, Portsmouth, NH 03801.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for PIROUETTE PHARMA INC. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
PIROUETTE PHARMA INC. is a registered filer with the SEC (CIK 1870611) and has filed since 2025-04-01. 2 filings are on record, the latest on 2026-03-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
PIROUETTE PHARMA INC.'s Form D of 2025-04-01 names CONOR CULLINANE, JOSEPH NEMMERS, PARINAZ MOTAMEDY and 2 more as its officers, directors or promoters.
Its new offerings report $3.43M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Conor Cullinane is named as Executive Officer and Director and Promoter on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 1 April 2025, one of 5 people that filing names.
Joseph Nemmers is named as Director on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 1 April 2025, one of 5 people that filing names.
Parinaz Motamedy is named as Director on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 1 April 2025, one of 5 people that filing names.
Matthew Kane is named as Executive Officer and Director and Promoter on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 1 April 2025, one of 5 people that filing names.
Elijah Kapas is named as Executive Officer and Promoter on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 1 April 2025, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2025-04-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about PIROUETTE PHARMA INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on PIROUETTE PHARMA INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PIROUETTE PHARMA INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist PIROUETTE PHARMA INC.You get an alert in MentionFox the next time this company shows up.
If you're behind PIROUETTE PHARMA INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for PIROUETTE PHARMA INC.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/pirouette-pharma-inc-form-d-25000001